LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform today announced poster presentations of preclinical data on EPX-102216 and EPX-105287, during the Keystone Symposia Neurobiology of Pain and Analgesia in Santa Fe, New Mexico.
